Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Concord grape juice increased HDL, lowered inflammatory marker linked to heart disease

17.11.2004


Study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology



Drinking Concord grape juice significantly increased HDL--the good cholesterol--and significantly lowered two markers of inflammation in people with stable coronary artery disease, according to results of a study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology. "In addition to HDL levels increasing, we saw significant decreases in the production of superoxide, a free radical, and soluble CD40 ligand, an inflammatory marker about which there is growing interest," explains Jane E. Freedman, M.D., Associate Professor of Medicine and Pharmacology, Boston University School of Medicine and an author of the study. "Platelet release of soluble CD40 ligand is thought to contribute to the development of atherosclerosis and vascular inflammation.

We have seen in previous studies of healthy subjects that drinking grape juice decreases superoxide production and inhibits platelet aggregation, yet its impact on the inflammatory properties of platelets had not been previously studied. The soluble CD40 ligand information is new and particularly interesting, given the growing interest in the link between this inflammatory marker and cardiovascular disease."


The positive increase in HDL levels is also noteworthy, according to Freedman. Historically, HDL increases have been linked to drinking red wine and attributed to the alcohol found in the wine. Given that Concord grape juice does not contain alcohol, researchers may now be looking more closely at the polyphenolic compounds found in both wine and grape juice as potential contributors to this effect.

"There has been great interest in the possible benefits of drinking red wine for people with cardiovascular disease," notes Freedman. "But it has been offset, to a certain extent, by concerns about promoting alcohol consumption. This has led to the exploration of non-alcoholic grape products. In the past, we have seen that Concord grape juice has shown strong antioxidant and platelet-inhibitory effects. This is the first study to show its positive effect on soluble CD40 ligand, an emerging marker of cardiovascular inflammation, even in subjects on a daily aspirin regimen."

The double blind, placebo-controlled study looked at 20 subjects, with a mean age of 63 years, who had previously been diagnosed with coronary artery disease and were on standard medications, including aspirin. "Because the patients were already on aspirin therapy, we didn’t see the significant platelet inhibition we typically get in subjects drinking the grape juice. This is not surprising, however, given aspirin’s potent effect on platelets."

Freedman cautions that her study is preliminary and that more work needs to be done in this area. Nonetheless, she notes that consumption of purple grape juice may suppress inflammatory indices that have been recently linked to cardiovascular disease.

The study comes on the heels of the release of the new USDA proanthocyanidin database in which purple grape juice made from Concord grapes tested higher in total proanthocyanidins than any other beverage tested on a per serving basis, including red wine, tea, cranberry juice cocktail and apple juice. Proanthocyanidins, a subset of polyphenols, are natural plant compounds that function as antioxidants and that have been linked to good health in a variety of ways.

Julie McQuain | EurekAlert!

More articles from Studies and Analyses:

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>